National Coverage Analysis (NCA)

Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection

CAG-00464N

Expand All | Collapse All

Contacts

Lead Analysts
Rachel Katonak
Rachel.katonak@cms.hhs.gov
410-786-8564
Lead Medical Officers
Carl Li, M.D.

History of Considerations

History Title ID View the document version
Original Consideration Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection CAG-00464N You are here